Literature DB >> 27588611

The P-Rex1/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses.

Marcelo G Kazanietz1, Laura Barrio-Real1, Victoria Casado-Medrano1, Martin J Baker1, Cynthia Lopez-Haber1.   

Abstract

Guanine nucleotide Exchange Factors (GEFs) are responsible for mediating GDP/GTP exchange for specific small G proteins, such as Rac. There has been substantial evidence for the involvement of Rac-GEFs in the control of cancer cell migration and metastatic progression. We have previously established that the Rac-GEF P-Rex1 is a mediator of actin cytoskeleton rearrangements and cell motility in breast cancer cells downstream of HER/ErbB receptors and the G-Protein Coupled Receptor (GPCR) CXCR4. P-Rex1 is highly expressed in luminal A and B breast cancer compared to normal mammary tissue, whereas expression is very low in basal breast cancer, and its expression correlates with the appearance of metastasis in patients. Here, we discuss the involvement of P-Rex1 as an effector of oncogenic/metastatic receptors in breast cancer and underscore its relevance in the convergence of receptor-triggered motile signals. In addition, we provide an overview of our recent findings describing a cross-talk between HER/ErbB receptors and CXCR4, and how this impacts on the activation of P-Rex1/Rac1 signaling, as well as highlight challenges that lie ahead. We propose a model in which P-Rex1 acts as a crucial node for the integration of upstream inputs from HER/ErbB receptors and CXCR4 in luminal breast cancer cells.

Entities:  

Keywords:  CXCR4; HER/ErbB receptors;; P-Rex1; Rac1; breast cancer

Mesh:

Substances:

Year:  2016        PMID: 27588611      PMCID: PMC5997144          DOI: 10.1080/21541248.2016.1221273

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  57 in total

1.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

Authors:  Ombretta Salvucci; Amélie Bouchard; Andrea Baccarelli; Jean Deschênes; Guido Sauter; Ronald Simon; Rosella Bianchi; Mark Basik
Journal:  Breast Cancer Res Treat       Date:  2005-12-13       Impact factor: 4.872

4.  The guanine-nucleotide-exchange factor P-Rex1 is activated by protein phosphatase 1α.

Authors:  Mark A Barber; Annick Hendrickx; Monique Beullens; Hugo Ceulemans; David Oxley; Sylvia Thelen; Marcus Thelen; Mathieu Bollen; Heidi C E Welch
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

5.  Rac-GAP-dependent inhibition of breast cancer cell proliferation by {beta}2-chimerin.

Authors:  Chengfeng Yang; Ying Liu; Federico Coluccio Leskow; Valerie M Weaver; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

6.  Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.

Authors:  Maria Soledad Sosa; Cynthia Lopez-Haber; Chengfeng Yang; Hongbin Wang; Mark A Lemmon; John M Busillo; Jiansong Luo; Jeffrey L Benovic; Andres Klein-Szanto; Hiroshi Yagi; J Silvio Gutkind; Ramon E Parsons; Marcelo G Kazanietz
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

7.  The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.

Authors:  Carmen Citterio; Mauricio Menacho-Márquez; Ramón García-Escudero; Romain M Larive; Olga Barreiro; Francisco Sánchez-Madrid; Jesús M Paramio; Xosé R Bustelo
Journal:  Sci Signal       Date:  2012-10-02       Impact factor: 8.192

8.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

9.  Characterization of P-Rex1 for its role in fMet-Leu-Phe-induced superoxide production in reconstituted COS(phox) cells.

Authors:  Baoming Nie; Ni Cheng; Mary C Dinauer; Richard D Ye
Journal:  Cell Signal       Date:  2010-01-13       Impact factor: 4.315

Review 10.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more
  5 in total

Review 1.  The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic.

Authors:  Victoria Casado-Medrano; Martin J Baker; Cynthia Lopez-Haber; Mariana Cooke; Shaofei Wang; Maria J Caloca; Marcelo G Kazanietz
Journal:  Biochem Soc Trans       Date:  2018-07-31       Impact factor: 5.407

2.  P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site.

Authors:  Jonathan D Marotti; Kristen E Muller; Laura J Tafe; Eugene Demidenko; Todd W Miller
Journal:  Int J Breast Cancer       Date:  2017-06-15

3.  P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.

Authors:  Laura Barrio-Real; Cynthia Lopez-Haber; Victoria Casado-Medrano; Alexander G Goglia; Jared E Toettcher; Maria J Caloca; Marcelo G Kazanietz
Journal:  Oncotarget       Date:  2018-06-19

Review 4.  Targeting Rac and Cdc42 GEFs in Metastatic Cancer.

Authors:  Maria Del Mar Maldonado; Julia Isabel Medina; Luis Velazquez; Suranganie Dharmawardhane
Journal:  Front Cell Dev Biol       Date:  2020-04-08

5.  NF1-RAC1 axis regulates migration of the melanocytic lineage.

Authors:  Lionel Larribère; Yohanes Cakrapradipta Wibowo; Nitin Patil; Mohammed Abba; Isabel Tundidor; Rubén Gerardo Aguiñón Olivares; Heike Allgayer; Jochen Utikal
Journal:  Transl Oncol       Date:  2020-09-04       Impact factor: 4.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.